Last reviewed · How we verify

ASCT conditioning — Competitive Intelligence Brief

ASCT conditioning (ASCT conditioning) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: High-dose chemotherapy conditioning regimen. Area: Oncology.

phase 3 High-dose chemotherapy conditioning regimen Oncology Small molecule Live · refreshed every 30 min

Target snapshot

ASCT conditioning (ASCT conditioning) — Prof. Dr. M. Dreyling (co-chairman). ASCT conditioning is a high-dose chemotherapy regimen used to prepare the bone marrow for autologous stem cell transplantation by eliminating malignant cells and creating space for donor stem cells to engraft.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
ASCT conditioning TARGET ASCT conditioning Prof. Dr. M. Dreyling (co-chairman) phase 3 High-dose chemotherapy conditioning regimen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (High-dose chemotherapy conditioning regimen class)

  1. Prof. Dr. M. Dreyling (co-chairman) · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). ASCT conditioning — Competitive Intelligence Brief. https://druglandscape.com/ci/asct-conditioning. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: